# FDA Inspection 1271020 - Octapharma Plasma, Inc. - May 15, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/d40ec9d8-13a7-43bf-8924-11534db3bb3b
Source feed: FDA_Inspections

> FDA Inspection 1271020 for Octapharma Plasma, Inc. on May 15, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271020
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2025-05-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1271020 - 2025-05-15](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/565417a6-19fa-4674-aa26-6b30a67800c6)
- [FDA Inspection 1068565 - 2018-09-21](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/06deb764-32bc-45e3-a02e-f111ce5ce7a0)
- [FDA Inspection 910554 - 2015-01-21](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/198d997e-6ba2-475b-8855-bdbd787a27f9)
- [FDA Inspection 801745 - 2012-10-01](https://www.globalkeysolutions.net/records/fda_inspections/octapharma-plasma-inc/1e1bab17-40a5-4c35-81d6-b3f759908a4f)

Company: https://www.globalkeysolutions.net/companies/octapharma-plasma-inc/ff480cea-56d8-4add-aac6-41396784a911

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d